House panel questions FDA’s track record combating illegal opioids


WASHINGTON (Reuters) – U.S. lawmakers fear the Food and Drug Administration is not doing enough to stop the flow of illegal drugs into the United States as the country works to combat the opioid epidemic.

U.S. Food and Drug Commissioner Scott Gottlieb attends an interview at Reuters headquarters in New York City, U.S., October 10, 2017. REUTERS/Eduardo Munoz

Republican and Democratic members on the House Energy and Commerce Committee questioned whether the FDA’s criminal investigators are effective at blocking illegal drugs at U.S. ports of entry, in a letter seen by Reuters.

“We have…



Read More Here

Be the first to comment on "House panel questions FDA’s track record combating illegal opioids"

Leave a comment

Your email address will not be published.


*